Articles On Polynovo (ASX:PNV)

Three S&P/ASX 200 Index (ASX: XJO) shares just scored significant broker upgrades. The analysts' bullish assessments for these companies, including share price gains of up to 13%, follow on the release of yesterday's earnings results....

ASX 200 healthcare shares are among the worst-performing market sectors on Tuesday, with the S&P/ASX 200 Health Care Index (ASX: XHJ) down 0.86% at the time of writing. Meantime, the S&P/ASX 200 Index (ASX: XJO) is also lower, dow...

Biotech doesn’t need another pandemic for a resurgence – it’s made a strong comeback regardless. Stockhead spoke with Andrew Chapman, head of Perth-based fundie Merchant Group – to learn why this is the case, and which are his top picks for...

June of 2015 was a special time. The vastly underrated Jurassic World was about to become the first film to make US$500m worldwide on its opening weekend and in Harare, President Robert Mugabe had just discarded the national currency in fav...

Morgans releases its ASX wound care report seeing value in Aroa Biosurgery, Avita Medical and PolyNovo Global wound care market is estimated to grow at a CAGR of 5.9% to reach US$28.6 billion by 2028 ASX wound care companies head towards p...

Xi and Biden set to agree on restricting fentanyl  Fentanyl is a synthetic opioid responsible for the opioids epidemic in the US We look at the best performing health stocks over the past couple of weeks   China’s President Xi is expected...

After yesterday's hiccup, the strong run the S&P/ASX 200 Index (ASX: XJO) has been on this November continued today. By the close of trading, the ASX 200 add...

Aroa Biosurgery forecasts business growth of up to 30% annually with product revenue guidance of NZ$73-$76 million in FY24 New study highlights positive outcomes using Myriad Matrix and Myriad Morcells in complex traumatic wounds Aroa focu...

Highlights The products of PolyNovo comprise NovoSorb Biodegradable Temporizing Matrix (BTM) and NovoSorb technology In FY23, PNV’s annual revenue zoomed by nearly 56.80%, backed by significant sales growth in the US market In FY24, r...

ASX tumbles after Nasdaq rout overnight Azure Minerals accepts takeover from Chliean giant SQM Megaport sinks 20pc after Q1 results   The ASX 200 dropped -0.8% on Thursday following a selloff on the Nasdaq and S&P 500 index overnight....

It's been a pretty depressing day for most ASX shares and the S&P/ASX 300 Index (ASX: XKO) this Thursday so far. At present, the ASX 300 has shed a horrid 0.86%, leaving the index at just 6,748.3 points. But let's talk about one ASX 30...

It's been a horrible start to the trading week for the S&P/ASX 200 Index (ASX: XJO) this Monday. After heavy falls last Thursday and Friday, investors hoping for a repri...

News relating to Novo Nordisk’s Ozempic has led to a selloff in some ASX stocks CSL, FPH, and RMD fell heavily last week But Goldman analysts say they won’t change ratings on these 3 stocks   Goldman Sachs analysts said they will make no...

The S&P/ASX 300 Index (ASX: XKO) has had a positive start to this Tuesday's trading session, shaking off the negative we saw yesterday. At the time of writing, the ASX 300 has gained a rosy 0.62%, putting the index back above 7,000 poi...

The Syrah Resources Ltd (ASX: SYR) share price is having a strong start to the day. In morning trade, the graphite producer's shares are up 5% to 49.5 cents. Why is the Syrah share price jumping? Investors have been buying Syrah's shares t...

Weekly update on stockbroker recommendation, target price, and earnings forecast changes. By Mark Woodruff Guide: The FNArena database tabulates the views of eight major Australian and international stockbrokers: Citi, Bell Potter, Macquari...

INOVIQ Limited (ASX: IIQ) has announced the appointment of David Williams as a Non-Executive Director and Chairman Elect, effective from the Annual General Meeting (AGM) scheduled for 29 November 2023. Mr Williams will succeed Dr Geoffrey C...

There's nothing like backing a winner, right? If you see ASX shares that are on an upward curve, and you feel like the business can continue the momentum, why wouldn't you jump on? Here are two such stocks that the team at Celeste Funds Ma...

ASX health sector falls in line with broader markets as macroeconomic factors continue to create volatility Dimerix soars on $230m licensing deal with ADVANZ PHARMA for DMX-200 into rare kidney disease US FDA approves Cyclofarm’s lung imag...

When a stock almost doubles in just one year, the natural thought for punters who don't own it is to think "It's too late to get in on that action". But ASX shares don't have memory. It doesn't care what's happened the past 12 months, one...

The S&P/ASX 200 Index (ASX: XJO) has returned to form and is pushing higher at last on Thursday. In afternoon trade, the benchmark index is up 0.5% to 6,924.9 points. Four ASX shares that are climbing more than most today are listed b...

The S&P/ASX 200 Index (ASX: XJO) has fought back from a tough start and is now trading just a fraction lower. At the time of writing, the benchmark index is down 2.2 points to 7,046.4 points. Four ASX shares that are trying their bes...

The S&P/ASX 200 Index (ASX: XJO) stock Scentre Group (ASX: SCG) has been hurting a lot. Since the start of 2023, the Scentre share price has fallen 14%. It's down 20% from 24 January 2023 and it's down around 40% from mid-January 2020....

Investing, like most other activities in life, requires practice and experience for any human to become competent at it. In fact, some people may never even reach competency even after years of training. So when those who have done it succ...

With apologies to Charles Dickens, it’s the best of times and the worst of times for wound care house Next Science (ASX:NXS) as it shapes itself up for a renewed market assault under a new CEO. On the positive side of the ledger, the compan...

L’Oréal to take minority stake in Chinese startup Shinehigh Innovation Shinehigh is developing supramolecular technology which could be used in the fashion industry Best and worst performing ASX biotechs over the past couple of weeks   Be...

The S&P/ASX 200 Index (ASX: XJO) is down 0.28% to 7,018.5 points in afternoon trade following a slump on Wall Street last night. Part of the burdensome weight on the share market's shoulders is the rising yield on bonds. Overnight, th...

Pro Medicus Limited (ASX: PME) shares were on fire on Tuesday despite the market weakness. The health imaging technology company's shares stormed 12% higher to a record high. Investors were scrambling to get hold of its shares after it an...

It was back to old, bad habits for the S&P/ASX 200 Index (ASX: XJO) during Tuesday's trading session. After the ASX 200 snapped its five-day losing streak yesterday with a tentative gain...

The S&P/ASX 200 Index (ASX: XJO) is out of form on Tuesday. In afternoon trade, the benchmark index is down 0.5% to 7,043.1 points. Four ASX shares that are not letting that hold them back are listed below. Here's why they are pushing...

It hasn't been a great day for the S&P/ASX 200 Index (ASX: XJO) and most ASX shares so far this Tuesday. At the time of writing, the ASX 200 has slipped by 0.71%. But that hasn't stopped one ASX exchange-traded fund (ETF) from hitting...

Another day, another set of 52-week highs for ASX uranium shares! Most uranium miners are rising on Tuesday, in contrast to the rest of the market. The S&P/ASX 200 Energy Index (ASX: XEJ) started the day higher but is now down 0.19%...

It's been a pretty awful start to this Tuesday's trading for the S&P/ASX 300 Index (ASX: XKO) and ASX 300 shares so far today. At present, the ASX 300 has slipped by 0.32% and is back to around 7,000 points. So given this slip for the...

Australian medical device company PolyNovo (ASX:PNV) has announced that it more than doubled its revenue in August compared to the same month last year.

Another 4% fall in the price of iron ore was almost enough to drive the S&P/ASX200 (INDEXASX: XJO) lower, with the materials sector falling 0.7% to open the week. Both BHP Group Ltd (ASX: BHP) and Rio Tinto Ltd (ASX: RIO) fell by more t...

The S&P/ASX 200 Index (ASX: XJO) has delighted investors hoping for a reprieve from the share market today with a green session. After falling every single trading day last week, the ASX...

The S&P/ASX 200 Index (ASX: XJO) is out of form on Monday. In afternoon trade, the benchmark index is down 0.2% to 7,057 points. Four ASX shares that are not letting that hold them back are listed below. Here's why they are rising:...

It's completely normal to worry about stock market risk and investing in ASX shares if you're a beginner investor just starting out (or wanting to) on your investing journey. Entrusting your cash to the whims of the markets is no easy feat...

Polynovo Ltd (ASX: PNV) shares have return from a short trading halt with a bang. In early afternoon trade, the medical device company's shares are up 12% to $1.37. Why are Polynovo shares racing higher? Investors have been fighting to get...

The TechnologyOne Ltd (ASX: TNE) share price is starting the week strongly. At the time of writing, the ASX 200 tech share is up 2.5% to $15.65. This compares favourably to the performance of the ASX 200 index, which is down 0.35%. Why is...

Chances are you've heard the phrase 'safe as houses' when discussing investing options for Australian investors. I'd be equally certain thought that the phrase 'safe as ASX shares' is one that most people haven't heard. The general consens...

It's been a happy end to the trading week indeed for the S&P/ASX 200 Index (ASX: XJO) and ASX shares this Friday. After having a fairly bumpy week, the ASX 200 went out in style today, recordi...

Polynovo Ltd (ASX: PNV) shares have struggled to find support in 2023. After a brief reprieve between May and August, the wound treatment company has seen its share price slapped with a 22.3% decline over the last 29 days. On Friday, shar...

The FDA has just approved an emergency use authorisation for new Covid-19 vaccines What is emergency use authorisation, and which ASX stocks have got it? We look at the best and worst performing ASX biotechs over the couple of weeks   On...

The Monadelphous Group Ltd (ASX: MND) share price is lifting on Wednesday morning. In early trade, the ASX 200 engineering company's shares are up 1% to $14.16. Why is this ASX 200 share rising? Investors have been buying Monadelphous shar...

The Liontown Resources Ltd (ASX: LTR) share price is rising on Wednesday. In morning trade, the lithium developer's shares are up 1% to $3.03. Why is the Liontown share price rising? This morning, Liontown revealed that it is business as u...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is fighting hard to start the week with a gain. At the time of writing, the benchmark index is up a fraction to 7,159.7 points. Four ASX shares that have failed to follow the marke...

The S&P/ASX 200 Index (ASX: XJO) has finished the trading week on another low note this Friday. After falling every day since Tuesday, the ASX 200 saw no reason to change course this session. By cl...

ASX health sector fall in line with broader markets as macroeconomic factors create uncertainty Clinuvel down as its European label expansion of SCENESSE knocked back pending further data 2023 biotech market darling elevated to the S&P...

It has been another busy week for Australia's top brokers. This has led to the release of a large number of broker notes. Three broker buy ratings that you might want to know more about are summarised below. Here's why brokers think these...